APA

Mayer S. E., Weiss N. S., Chubak J., Doody D. R., Carlson C. S., Makar K. W., Wurscher M. A. & Malone K. E. (20190304). CYP2D6-inhibiting medication use and inherited CYP2D6 variation in relation to adverse breast cancer outcomes after tamoxifen therapy. : Cancer causes & control : CCC.

Chicago

Mayer Sophie E, Weiss Noel S, Chubak Jessica, Doody David R, Carlson Christopher S, Makar Karen W, Wurscher Michelle A and Malone Kathleen E. 20190304. CYP2D6-inhibiting medication use and inherited CYP2D6 variation in relation to adverse breast cancer outcomes after tamoxifen therapy. : Cancer causes & control : CCC.

Harvard

Mayer S. E., Weiss N. S., Chubak J., Doody D. R., Carlson C. S., Makar K. W., Wurscher M. A. and Malone K. E. (20190304). CYP2D6-inhibiting medication use and inherited CYP2D6 variation in relation to adverse breast cancer outcomes after tamoxifen therapy. : Cancer causes & control : CCC.

MLA

Mayer Sophie E, Weiss Noel S, Chubak Jessica, Doody David R, Carlson Christopher S, Makar Karen W, Wurscher Michelle A and Malone Kathleen E. CYP2D6-inhibiting medication use and inherited CYP2D6 variation in relation to adverse breast cancer outcomes after tamoxifen therapy. : Cancer causes & control : CCC. 20190304.